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AbsTrACT 
background it remains unclear what underlies 
the greater risk of asthma reported among children 
conceived by assisted reproductive technologies (art).
Objective Our aim was to clarify the role of parental 
subfertility and unmeasured confounding on the 
association between art and childhood asthma, and 
to examine the possibility for common mechanisms 
underlying parental subfertility and miscarriages 
influencing asthma pathogenesis.
Methods We used data from national norwegian 
health registries (n=474 402) and the norwegian Mother 
and child cohort Study (MoBa) (n=75 797). We used 
log-linear regression to estimate overall associations, and 
fixed-effects logistic regression to estimate associations 
within siblings.
results art offspring had greater asthma risk, 
the adjusted relative risk (arr) was 1.20 (95% ci 
1.09 to 1.32) in the registry-based cohort, and 1.42 
(95% ci 1.14 to 1.76) in MoBa. the sibling analysis 
yielded similar associations, although the ci included 
the null value. the elevated asthma risk among art 
offspring was attenuated when they were compared 
with spontaneously conceived offspring with time to 
conception >12 months, arr 1.22 (95% ci 0.95 to 
1.57). asthma risk also increased with maternal history 
of early miscarriages (≤12 weeks), with an arr of 1.07 
(95% ci 1.03 to 1.11) for one, arr 1.18 (95% ci 1.10 
to 1.26) for two and arr 1.24 (95% ci 1.12 to 1.37) for 
three or more.
Conclusion Our findings indicate that both 
parental subfertility and characteristics related to 
the art procedure itself might increase offspring 
asthma risk, although this needs to be confirmed 
in future studies, and further suggest that common 
mechanisms underlying parental subfertility and 
recurrent miscarriages might influence offspring asthma 
pathogenesis.
InTrOduCTIOn
An estimated one in four couples globally require 
assistance to conceive according to WHO.1 Assisted 
reproductive technologies (ART) are associated 
with greater risk of adverse pregnancy outcomes 
and may also have long-term consequences for both 
the mother and child.2 3 With regard to whether the 
risk of asthma is increased in ART offspring, there 
is inconsistent evidence, with studies reporting both 
null,4–6 and positive findings.2 7–11 
Only one previous population-based study 
attempted to distinguish the roles of underlying 
subfertility (measured by time to conception) and 
ART in relation to asthma risk.7 It therefore remains 
unclear whether an increased risk of asthma in 
ART offspring could be explained by character-
istics of women who suffer from subfertility, or 
a direct effect of ART procedures. Furthermore, 
no previous study compared the risk of asthma 
among ART offspring with their spontaneously 
conceived sibling, to examine the role of unmea-
sured confounding by maternal background char-
acteristics that remain stable between deliveries.12 13
There is evidence of common determinants 
of subfertility and risk of recurrent miscarriages, 
including immunological mechanisms.14 A few 
previous studies of maternal history of miscar-
riages and asthma risk suggest a positive associa-
tion.15 16 However, these studies did not distinguish 
between early versus late miscarriages. Early 
miscarriages might be more likely to be explained 
by maternal-fetal incompatibility or chromosomal 
aberrations.14
Key messages
What is the key question?
 ► What is the role for parental subfertility and 
unmeasured confounding on the association 
between assisted reproductive technologies 
(ART) and childhood asthma, and are there 
common mechanisms underlying parental 
subfertility and miscarriages influencing asthma 
pathogenesis?
What is the bottom line?
 ► Our findings indicate that both parental 
subfertility and characteristics related to the 
ART procedure itself might increase offspring 
asthma risk, although this needs to be 
confirmed in future studies, and further suggest 
that common mechanisms underlying parental 
subfertility and recurrent miscarriages might 
influence offspring asthma pathogenesis.
Why read on?
 ► This population-based study provides novel 
insight into the underlying mechanisms behind 
the greater risk of asthma previously reported 
among children conceived by ART.
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Our aim was to clarify the role of parental subfertility and 
unmeasured confounding on the association between ART and 
childhood asthma, and to examine the possibility for common 
mechanisms underlying parental subfertility and miscarriages 
influencing asthma pathogenesis.
MATerIAls And MeThOds
norwegian national registry Cohort
We linked information from the Medical Birth Registry of 
Norway (MBRN),17 and the Norwegian Prescription Database 
(NorPD), for all children born in Norway between January 1998 
and March 2009. We included children who had reached 8 years 
by the time of the registry linkage in April 2017. We excluded 
children who died or emigrated before age 8, those with missing 
maternal identification number, children from multiple births, 
children with a birth weight <500 g, children with a gestational 
age <22 weeks and children with missing exposure information, 
leaving a total of 474 402 children in the analysis (figure 1A). 
The norwegian Mother and Child Cohort study
The Norwegian Mother and Child Cohort Study (MoBa) recruited 
pregnant women across Norway between 1999 and 2008 at the 
time of the invitation to the routine ultrasound screening, at 
approximately gestational week 18.18 19 Of the eligible women, 
41% participated, and all participants gave a written informed 
consent. The cohort includes >95 000 women and 114 500 
offspring. Notably, all children in MoBa were also included in 
the registry analysis. We used data available in November 2015 
(V.9 of the quality assured data files). Information obtained 
through questionnaires in MoBa was linked to the MBRN and 
NorPD. A total of 75 797 singletons in MoBa had reached 8 
years by the time of data linkage in July 2015, had information 
from questionnaires administered at 18 gestational weeks and 
were included in the current study (figure 1B).
Assisted reproductive technologies and measures of parental 
subfertility
The MBRN provided information on whether the offspring 
was conceived by ART or not (yes vs no). For the register-based 
cohort, we also examined different subgroups of ART, including 
in vitro fertilisation (IVF), intracytoplasmic sperm injection 
(ICSI) and ‘other/unknown’ methods. In MoBa, additional 
self-reported measures of parental subfertility included previous 
treatment for unwanted childlessness (yes vs no) and time to 
conception (<6 months, 6–12 months and >12 months).
Maternal history of miscarriages
The MBRN included self-reported information on the number 
of previous miscarriages (0, 1, 2 and 3 or more) the first 12 gesta-
tional weeks (early), and the number of miscarriages between 
12 and 23 gestational weeks (late). In MoBa, the number of 
previous miscarriages was self-reported through a questionnaire. 
The mother reported whether each previous pregnancy had 
resulted in a live birth, induced abortion or fetal death and the 
gestational week a fetal death had occurred. A fetal death that 
occurred during the first 22 gestational weeks was defined as a 
miscarriage (0, 1, 2 and 3 or more).
Figure 1 Illustration of sample selection. MoBa, Norwegian Mother and Child Cohort Study.
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Childhood asthma
We defined childhood asthma using dispensed asthma medica-
tions in the NorPD, which is coded according to the Anatomical 
Therapeutic Chemical Classification System. Asthma medica-
tions included inhaled short-acting and long-acting beta(2)-ag-
onists (R03AC), inhaled corticosteroids (R03BA), fixed-dose 
combinations of inhaled beta(2)-agonists and corticosteroids 
(R03AK) and leukotriene antagonists (R03DC). We classified 
children as having asthma at age 7 if at least one prescription 
for asthma medications was dispensed in the 12 months before 
the seventh birthday, in addition to a second dispensed prescrip-
tion within 12 months after the first. In a secondary analysis in 
MoBa, we defined asthma at age 7 based on maternal report of 
doctor-diagnosed asthma, in combination with either symptoms 
or use of asthma medications in the past 12 months.
Covariates
The MBRN provided information on maternal age at delivery 
(<25, 26–29, 30–34 and 25 and older), parity (0, 1, 2, 3 or more), 
pre-eclampsia (yes vs no), in addition to child sex, low birth weight 
(<2500 g), preterm birth (gestational age <37 completed weeks) 
and delivery by caesarean section (yes vs no). We used additional 
information on maternal current asthma (yes vs no), smoking 
during pregnancy (no, only in the beginning of pregnancy and still 
smoking at the end of pregnancy) and folate supplement intake 
(no, started before pregnancy and started during pregnancy) from 
MBRN for the register-based cohort. For MoBa participants, 
self-reported information obtained through questionnaires was 
available for maternal current asthma (yes vs no), smoking (no, 
quit by 18 gestational weeks and still smoking after 18 gestational 
weeks), folate intake (no, started before pregnancy and started 
during pregnancy) and prepregnancy body mass index (<18.5, 
18.5–24.9, 25–29.9 and 30 or higher kg/m2).
statistical analysis
First, we examined the associations of ART, whether the parents 
had previously been treated for unwanted childlessness, and 
time to conception, in relation to asthma at age 7. Second, we 
examined the association between maternal history of miscar-
riages and risk of childhood asthma. We estimated the associ-
ations using log-binomial regression, reporting relative risks 
(RR) and 95% CIs. We accounted for the dependency between 
siblings by using robust cluster variance estimation. In the regis-
ter-based analyses, we adjusted for maternal age, parity and 
maternal current asthma. We explored additional adjustment for 
maternal smoking among the 83% of children for whom this 
Table 1 Distribution of background characteristics
background characteristics
registry cohort
n=474 402
n (%)
Moba
n=75 797
n (%)
Maternal age at delivery, years
  <25 79 803 (16.8) 8791 (11.6)
  25–29 155 866 (32.9) 25 367 (33.5)
  30–34 159 001 (33.5) 29 024 (38.3)
  35 and older 79 732 (16.8) 12 615 (16.6)
Maternal parity
  0 193 503 (40.8) 33 059 (43.6)
  1 170 737 (36.0) 27 291 (36.0)
  2 78 163 (16.5) 12 009 (15.8)
  3+ 31 999 (6.8) 3438 (4.5)
Maternal education
  Less than high school NA 6698 (8.8)
  High school NA 23 485 (31.0)
  Up to 4 years of college NA 30 223 (39.9)
  >4 years of college NA 15 018 (19.8)
  Missing NA 373 (0.5)
Maternal prepregnancy body mass index
  <18.5 NA 2313 (3.1)
  18.5–24.9 NA 47 768 (63.0)
  25–29.9 NA 16 391 (21.6)
  30 or higher NA 7122 (9.5)
  Missing NA 2203 (2.9)
Maternal folic acid supplement intake
  No 271 981 (57.3) 16 020 (21.1)
  Started before pregnancy 76 333 (16.1) 30 835 (40.7)
  Started during pregnancy 124 732 (26.3) 28 942 (38.2)
  Missing 1356 (0.3) 0 (0)
Maternal smoking during pregnancy
  No 317 226 (66.9) 56 564 (74.6)
  Only at the beginning of 
pregnancy (register)/quit by 
18 weeks (MoBa)
27 929 (5.9) 10 811 (14.3)
  Still smoking end of pregnancy 
(register)/smoked after 18 weeks 
(MoBa)
48 855 (10.3) 8057 (10.6)
  Missing 80 392 (17.0) 365 (0.5)
Maternal current asthma
  No 454 114 (95.7) 73 220 (96.6)
  Yes 20 288 (4.3) 2577 (3.4)
Maternal pre-eclampsia
  No 456 100 (96.1) 72 914 (96.2)
  Yes 18 302 (3.9) 2883 (3.8)
Child gender
  Male 243 413 (51.3) 38 811 (51.2)
  Female 230 989 (48.7) 36 986 (48.8)
Child preterm birth (<37 gestational weeks)
  No 449 218 (94.7) 71 849 (94.8)
  Yes 25 184 (5.3) 3646 (4.8)
Continued
background characteristics
registry cohort
n=474 402
n (%)
Moba
n=75 797
n (%)
  Missing 0 (0) 302 (0.4)
Child low birth weight (<2500 g)
  No 458 572 (96.7) 73 611 (97.1)
  Yes 15 830 (3.3) 2146 (2.8)
  Missing 0 (0) 40 (0.1)
Child delivered by caesarean section
  No 404 328 (85.2) 65 288 (86.1)
  Yes 70 074 (14.8) 10 509 (13.9)
MoBa, Norwegian Mother and Child Cohort Study. 
Table 1 Continued 
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information was available. In MoBa, we adjusted for maternal 
age, parity, education, smoking during pregnancy, prepregnancy 
body mass index and asthma. We further considered whether 
the associations of interest were mediated by low birth weight, 
preterm birth, pre-eclampsia or delivery by caesarean section. 
These pregnancy complications were conceptualised as potential 
mediators under the assumption that parental fertility problems 
and maternal history of miscarriages might increase the risk of 
adverse pregnancy outcomes in subsequent pregnancies, and that 
these adverse pregnancy outcomes confer an increased risk of 
asthma in the offspring (see online supplementary figure S1). 
We conducted a logistic decomposition20 of the direct and indi-
rect effects of the associations of maternal fertility problems and 
history of miscarriages with offspring asthma according to these 
adverse pregnancy outcomes. In the register-based cohort, we 
also compared sibling pairs discordant for asthma, using fixed-ef-
fects/conditional logistic regression, reporting ORs and 95% CIs.
To examine the role of subfertility as opposed to character-
istics of the ART procedure, we compared the risk of asthma 
among children in MoBa conceived by ART first with sponta-
neously conceived children born to parents who had tried to 
conceive for >12 months, and second to children of parents 
previously treated for unwanted childlessness. We conducted a 
number of sensitivity analyses. We chose not to adjust for folate 
supplement intake in the main model, since we did not have 
strong evidence to support that it might influence the exposures 
of interest. However, we explored additional adjustment for 
folate supplement intake in a secondary analysis. Furthermore, 
we stratified the associations by maternal asthma and preterm 
birth. Less than 8% of children had missing information on 
one or more covariates, and we therefore present results from a 
complete-case analysis. All analyses were conducted using Stata 
V.14 (StataCorp, College Station, Texas, USA).
resulTs
distribution of background characteristics
Among the 474 402 children in the register-based cohort, 20 189 
(4.3%) had asthma at age 7 defined by dispensed medications. 
Similarly, among the 75 797 children in the analysis of MoBa, 
3229 (4.3%) children had received asthma medications. Mothers 
of children included in the registry-based analysis were older 
and less likely to be smokers than those excluded due to missing 
information on the history of miscarriages (see online supple-
mentary table S1). However, the distribution of adverse preg-
nancy outcomes and childhood asthma was similar. Children in 
the register-based cohort had mothers who were younger, more 
likely to smoke and more likely to have asthma, as compared 
with the children in MoBa (table 1). The children in the regis-
ter-based cohort were also more likely to be preterm or low birth 
weight (table 1). Background characteristics among children in 
MoBa according to conception by ART, and whether the parents 
had tried to conceive for more than 12 months, is displayed in 
online supplementary table S2.
Conception by assisted reproductive technologies and 
measures of parental subfertility in relation to childhood 
asthma
Children conceived by ART had a higher risk of childhood 
asthma both in the register-based cohort, adjusted RR 1.20 
(95% CI 1.09 to 1.32), and in MoBa, adjusted RR 1.42 (95% 
CI 1.14 to 1.76) (table 2). The positive associations with asthma 
were similar across the different subgroups of ART, including 
IVF, ICSI and ‘other/unspecified’ methods (table 2). The analysis 
of siblings discordant for childhood asthma in the register-based 
cohort yielded an association of a similar magnitude with ART, 
adjusted OR 1.20 (95% CI 0.85 to 1.71), although the CI was 
widened due to the smaller sample size (table 3). In MoBa, we 
further observed increased risk of asthma in children of parents 
previously treated for childlessness, adjusted RR 1.26 (95% CI 
1.12 to 1.42), and children of parents who had tried to conceive 
for >12 months, adjusted RR 1.19 (95% CI 1.06 to 1.34) 
(table 4). When we compared the risk of asthma among children 
conceived by ART with spontaneously conceived children of 
parents who had tried to conceive for >12 months, the adjusted 
RR was 1.22 (95% CI 0.95 to 1.57). Similarly, comparing ART 
children with spontaneously conceived children of parents 
who had previously been treated for unwanted childlessness, 
the adjusted RR for asthma was 1.23 (95% CI 0.95 to 1.58) 
(table 5). There was a modest indirect effect of adverse pregnancy 
outcomes on the association between parental fertility problems/
Table 2 Association between conception by assisted reproductive technologies and childhood asthma at 7 years
study population
Conceived by assisted 
reproductive technologies n n cases (%)
unadjusted
rr (95% CI)
Adjusted*
rr (95% CI)
Register-based cohort No 466 034 19 760 (4.2) 1 1
Yes (total) 8368 429 (5.1) 1.21 (1.10 to 1.33) 1.20 (1.09 to 1.32)
Yes (IVF) 7339 377 (5.1) 1.21 (1.10 to 1.34) 1.20 (1.08 to 1.33)
Yes (ICSI) 483 25 (5.2) 1.22 (0.83 to 1.79) 1.21 (0.83 to 1.76)
Yes (other/unspecified) 546 27 (5.0) 1.17 (0.81 to 1.69) 1.15 (0.79 to 1.65)
MoBa No 74 406 3144 (4.2) 1 1
Yes 1391 85 (6.1) 1.45 (1.17 to 1.78) 1.42 (1.14 to 1.76)
*The analysis of the register-based cohort was adjusted for maternal age, parity and maternal current asthma. The analysis of MoBa was adjusted for maternal age, parity, 
education, smoking during pregnancy, prepregnancy BMI and maternal current asthma.
BMI, body mass index; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilisation; MoBa, Norwegian Mother and Child Cohort Study; RR, relative risk.
Table 3 Sibling analysis of conception by assisted reproductive 
technologies and childhood asthma at 7 years in the registry-based 
cohort
Conceived 
by assisted 
reproductive 
technologies n controls n cases
unadjusted
Or (95% CI)
Adjusted*
Or (95% CI)
No 10 171 8793 1 1
Yes 123 130 1.26 (0.89 to 1.79) 1.20 (0.85 to 1.71)
*Adjusted for maternal age, parity and maternal current asthma.
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use of ART with offspring asthma risk (see online supplementary 
table S3 and S4), and the observed associations were therefore 
mostly not explained by these pathways.
Maternal history of miscarriages and childhood asthma
There was a dose-response relationship between risk of childhood 
asthma and maternal history of miscarriages the first 12 gestational 
weeks in the register-based analyses, with an adjusted RR of 1.07 
(95% CI 1.03 to 1.11) for one, an adjusted RR of 1.18 (95% CI 
1.10 to 1.26) for two and an adjusted RR of 1.24 (95% CI 1.12 to 
1.37) for three or more (table 6). In contrast, there was no strong 
evidence of an association with miscarriages between 12 and 23 
gestational weeks (table 6). In MoBa, maternal history of miscar-
riages the first 22 gestational weeks was positively associated with 
asthma, but the CIs included the null value (table 6). Adverse preg-
nancy outcomes were found to mediate only a minor part of the 
association between maternal history of miscarriages and childhood 
asthma risk (see online supplementary table S5).
sensitivity analyses
When using maternal-reported asthma at age 7 as the outcome, 
most associations were of similar magnitude as observed in the 
main analysis (see online supplementary table S6). Additional 
adjustment for folate supplement intake did not change the find-
ings, nor did adjustment for maternal smoking in the register-based 
cohort among the subgroup of children with this information avail-
able (results not presented). Stratified analyses of the associations 
by maternal asthma (see online supplementary tables S7-S9) and 
preterm birth (see online supplementary tables S10-S12) showed no 
strong evidence of an interaction. Additional multivariable adjust-
ment of the association between maternal history of miscarriages 
and asthma risk for use of ART did not change the observed associ-
ations (see online supplementary table S13).
dIsCussIOn
We observed a higher risk of childhood asthma among chil-
dren conceived by ART. This increased risk of asthma was not 
completely explained by a role of parental underlying subfertility, 
as indicated by our comparison with spontaneously conceived 
children born to parents who had tried to conceive for >12 
months. However, the independent roles of ART procedures 
from parental underlying subfertility on asthma risk needs to be 
confirmed in future studies. The higher risk of asthma among 
ART offspring is unlikely to be explained by unmeasured maternal 
background characteristics that remained stable between deliv-
eries, as a similar increased risk was observed when we compared 
children conceived by ART with their spontaneously conceived 
siblings. We also found a positive dose-response relationship 
between maternal history of early miscarriages and childhood 
asthma risk. The incremental increased risk of asthma according 
to maternal history of early miscarriages, lends some support to 
the notion that there might be common mechanisms underlying 
parental subfertility and recurrent miscarriages that play a role in 
offspring asthma pathogenesis.
strengths and limitations
The main strengths of our study include information on several 
measures of parental fertility. Other benefits included the avail-
ability of two datasets with individual strengths, and the possi-
bility of using a sibling comparison to examine the role of 
unmeasured confounding. With regard to limitations, we relied 
on maternal report of measures of fertility and history of miscar-
riages, which might have resulted in misclassification. We cannot 
exclude the possibility of some bias by selection due to the initial 
participation rate in MoBa (41%) or by the exclusion of children 
with missing information on maternal history of miscarriages 
from the registry linkage (20%). Women who provided informa-
tion on the number of previous miscarriages to the birth registry 
were slightly older, had a higher parity, were less likely to smoke 
and more likely to have a history of asthma. However, as we 
observed a similar distribution of childhood asthma among those 
included and excluded from the study, a selection bias is less 
likely to have influenced the results.21 Compared with all women 
Table 4 Association between measures of parental fertility and childhood asthma at 7 years in the MoBa
exposure exposure group n n cases (%)
unadjusted
rr (95% CI)
Adjusted*
rr (95% CI)
Previously treated for unwanted 
childlessness
No 68 011 2827 (4.2) 1 1
Yes 6018 325 (5.4) 1.30 (1.16 to 1.46) 1.26 (1.12 to 1.42)
Time to conception <6 months 60 485 2525 (4.2) 1 1
6–12 months 9431 386 (4.1) 0.98 (0.88 to 1.09) 0.98 (0.88 to 1.09)
>12 months 5881 318 (5.4) 1.30 (1.16 to 1.45) 1.19 (1.06 to 1.34)
*Adjusted for maternal age, parity, education, smoking during pregnancy, prepregnancy BMI and maternal current asthma.
BMI, body mass index; MoBa, Norwegian Mother and Child Cohort Study; RR, relative risk. 
Table 5 Comparing the risk of asthma at 7 years among children conceived by assisted reproductive technologies with children of parents who 
tried to become pregnant for 12 months or were previously treated for unwanted childlessness in the MoBa
exposure n n cases (%)
unadjusted
rr (95% CI)
Adjusted*
rr (95% CI)
Previously treated for unwanted childlessness 4653 244 (5.2) 1 1
Conceived by assisted reproductive technologies 1391 85 (6.1) 1.17 (0. 92 to 1.48) 1.23 (0.95 to 1.58)
Time to conception >12 months 4964 262 (5.3) 1 1
Conceived by assisted reproductive technologies 1391 85 (6.1) 1.16 (0.91 to 1.47) 1.22 (0.95 to 1.57)
*Adjusted for maternal age, parity, education, smoking during pregnancy, prepregnancy BMI and maternal current asthma.
BMI, body mass index; MoBa, Norwegian Mother and Child Cohort Study; RR, relative risk. 
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who gave birth in Norway during the recruitment period, partic-
ipants in MoBa are under-represented by the youngest mothers, 
women with more than two previous deliveries, smokers and 
women with a history of stillbirths.22 Our findings could also be 
influenced by ascertainment bias, if mothers who have experi-
ence fertility problems might are more likely to take their children 
to the doctor for respiratory problems. We relied on dispensed 
asthma medications to define asthma, but we did not have infor-
mation on whether the medication was actually used. However, 
maternal report that the child used asthma medications during 
this age period shows a high concordance with dispensed medi-
cations (sensitivity 85% and specificity 98%).23 By requiring a 
second dispensed prescription within 12 months after the first, 
the probability that medications was not used is reduced. We 
did not have information on maternal asthma control/symptoms 
during pregnancy. We therefore cannot exclude the possibility 
that the severity of maternal asthma symptoms during pregnancy 
could play a role in the associations of interest.
The point estimates from the main analysis and sibling analysis 
for the association between ART and asthma were identical in the 
registry-based cohort, even though the smaller number in the sibling 
analysis did not provide the power to achieve statistical signifi-
cance. Sibling analyses are also more vulnerable to confounding 
by parental background characteristics that change between deliv-
eries.12 Examples of parental background characteristics that might 
have changed between deliveries that we were not able to control 
for include parental asthma severity, changes in complex lifestyle 
characteristics (eg, diet) that are difficult to measure accurately and 
whether the parents moved resulting in different environmental 
exposures. For these unmeasured characteristics to act as potential 
confounders, they would have to be associated with both measures 
of parental fertility and childhood asthma risk.
Comparison with previous studies
The findings from our study are in line with previous studies 
reporting a positive association between ART and childhood 
asthma.2 7–11 The number of ART children in previous studies 
ranged from 59 to 31 918, with relative measures of associa-
tions with asthma ranging from an OR of 1.28 to 2.65. One 
previous study explored a stratified analysis by preterm birth, 
and found that the positive association between ART and asthma 
was of a greater magnitude among children born preterm,10 
which contrasts our findings that the associations were overall 
of a similar magnitude among children born term and preterm. 
The UK Millennium Cohort Study is the only previous popu-
lation-based study that was able to compare the risk of asthma 
among children conceived by ART with the risk among children 
of parents who had tried to conceive for >12 months, yielding 
RRs of 1.98 (95% CI 1.06 to 3.72) and 1.59 (95% CI 0.88 to 
2.89) for asthma at age 5 and 7, respectively.7
Our study also supports findings from two previous studies 
that looked at maternal history of miscarriages and risk of 
child asthma. A Finnish hospital-based study of 40 914 women 
reported a higher risk of asthma among children of mothers with 
a history of two or more miscarriages, adjusted OR 1.25 (95% CI 
1.04 to 1.51).15 Another Finnish register-based study, including 
21 038 children with asthma and 21 038 age-matched controls, 
indicated a positive association between maternal history of at 
least one miscarriage and asthma risk, adjusted OR 1.17 (95% 
CI 1.10 to 1.25).16 Our study is therefore the first to provide 
evidence for a positive dose-response relationship between 
maternal history of miscarriages and asthma risk. Furthermore, 
we show that the increased risk of asthma in relation to miscar-
riages is restricted to early miscarriages the first 12 gestational 
weeks, as we found no evidence to support an association with 
miscarriages between 12 and 23 gestational weeks.
Potential explanatory mechanisms
Since we observed associations with different measures of 
parental fertility, and our results indicate some evidence of an 
increased risk of asthma among ART children when compared 
with spontaneously conceived offspring of subfertile parents, we 
believe that there is evidence for both a role of subfertility and 
the ART procedures on the risk of childhood asthma. However, 
it is also possible that the increased risk of asthma among chil-
dren delivered by ART, when compared with children of parents 
who tried to become pregnant for >12 months, partly reflects 
the severity of the underlying subfertility of the parents.
It is plausible that factors related to the ART procedure itself 
might have a direct effect on risk of asthma, as these procedures 
may influence the embryo and the fetal environment.24–26 Several 
steps in the ART treatment may alter the natural course of the 
fetal development, for example, medications taken to induce 
ovulation and to ensure that the pregnancy stays intact during the 
Table 6 Association between maternal history of miscarriages and childhood asthma at 7 years
study population exposure exposure group n n cases (%)
unadjusted
rr (95% CI)
Adjusted*
rr (95% CI)
Register-based 
cohort
Number of miscarriages 
within the first 12 
gestational weeks
None 374 866 15 628 (4.2) 1 1
1 73 323 3256 (4.4) 1.07 (1.03 to 1.11) 1.07 (1.03 to 1.11)
2 18 415 902 (4.9) 1.17 (1.10 to 1.26) 1.18 (1.10 to 1.26)
3 or more 7798 403 (5.2) 1.24 (1.12 to 1.37) 1.24 (1.12 to 1.37)
Number of miscarriages 
between 12 and 23 
gestational weeks
None 448 198 18 979 (4.2) 1 1
1 11 086 546 (4.9) 1.16 (1.07 to 1.27) 1.21 (1.11 to 1.32)
2 1273 53 (4.2) 0.98 (0.75 to 1.29) 1.04 (0.79 to 1.36)
3 or more 418 18 (4.3) 1.02 (0.65 to 1.60) 1.04 (0.66 to 1.65)
MoBa Number of miscarriages 
within the first 22 
gestational weeks
None 60 982 2564 (4.2) 1 1
1 11 364 499 (4.4) 1.04 (0.95 to 1.15) 1.06 (0.96 to 1.16)
2 2555 123 (4.8) 1.14 (0.96 to 1.37) 1.18 (0.98 to 1.41)
3 or more 896 43 (4.8) 1.14 (0.85 to 1.53) 1.14 (0.85 to 1.53)
*The analysis of the register-based cohort was adjusted for maternal age, parity and maternal current asthma. The analysis of MoBa was adjusted for maternal age, parity, 
education, smoking during pregnancy, prepregnancy BMI and maternal current asthma.
BMI, body mass index; MoBa, Norwegian Mother and Child Cohort Study; RR, relative risk. 
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early phases, the type of medium used for the culture, freezing 
and thawing cycles, the possibility of polyspermic fertilisation, the 
hormonal environment and/or manipulation of the embryo.24–26
We propose that common immunological mechanism might 
plausibly underlie the increased risk of asthma we observed both 
among children of mothers who suffer from subfertility and 
miscarriages, since immunological mechanisms contributes to 
both problems conceiving and repeat pregnancy losses.27–30 The 
T helper (Th)1/Th2 balance has a role in ensuring a successful 
pregnancy, with an overexpression of Th1 immunity being linked 
to recurrent miscarriages, whereas Th2 immunity contributes to 
maternal immune tolerance towards the developing fetus.28 Since 
asthma is a disease with elevated Th2 immunity, it seems less 
likely that the elevated Th1 immunity in women suffering from 
subfertility explains our observations. In contrast, the greater 
levels of Th17 cells found in women with recurrent miscarriages 
might at least partly explain the associations.28 29 31 32 Another 
potential mechanisms is the expression of killer immunoglob-
ulin-like receptor genes, which seems to play a role in repro-
ductive failure, including the risk of pre-eclampsia, intrauterine 
growth restriction and recurrent spontaneous abortions.33
COnClusIOn
Our findings provide some evidence to support that both 
parental subfertility and characteristics related to the ART proce-
dure might increase offspring asthma risk, although this needs 
to be confirmed in future studies. Our results also suggest that 
common mechanisms underlying parental subfertility and recur-
rent miscarriages might influence offspring asthma pathogenesis.
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